Brean Capital Initiates Coverage on Markel Group (NYSE:MKL)

Brean Capital started coverage on shares of Markel Group (NYSE:MKL) in a research note issued to investors on Tuesday. The brokerage set a “neutral” rating and a $2,100.00 price target on the insurance provider’s stock. Brean Capital’s price objective indicates a potential upside of 10.87% from the company’s current price.

Other equities research analysts also recently issued research reports about the stock. Weiss Ratings restated a “buy (b+)” rating on shares of Markel Group in a research report on Monday, December 29th. Truist Financial boosted their target price on shares of Markel Group from $2,000.00 to $2,100.00 and gave the company a “hold” rating in a research note on Friday, February 6th. Zacks Research lowered Markel Group from a “strong-buy” rating to a “hold” rating in a report on Monday, January 19th. Finally, Wall Street Zen raised Markel Group from a “hold” rating to a “buy” rating in a research report on Saturday, March 14th. Two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, Markel Group has an average rating of “Hold” and an average price target of $2,100.00.

Markel Group Trading Up 0.3%

Shares of MKL traded up $4.94 during midday trading on Tuesday, hitting $1,894.10. The stock had a trading volume of 1,417 shares, compared to its average volume of 48,216. Markel Group has a fifty-two week low of $1,621.89 and a fifty-two week high of $2,207.59. The business has a 50-day simple moving average of $2,030.73 and a two-hundred day simple moving average of $2,022.87. The firm has a market cap of $23.83 billion, a P/E ratio of 11.13 and a beta of 0.77. The company has a current ratio of 0.63, a quick ratio of 0.63 and a debt-to-equity ratio of 0.23.

Insider Transactions at Markel Group

In other Markel Group news, CEO Simon Wilson sold 100 shares of the stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $2,079.48, for a total value of $207,948.00. Following the completion of the sale, the chief executive officer owned 2,397 shares in the company, valued at $4,984,513.56. This represents a 4.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.66% of the stock is currently owned by insiders.

Institutional Trading of Markel Group

Several hedge funds and other institutional investors have recently modified their holdings of the company. Canerector Inc. boosted its stake in shares of Markel Group by 191,036.0% during the 3rd quarter. Canerector Inc. now owns 10,703,616 shares of the insurance provider’s stock worth $20,458,463,000 after acquiring an additional 10,698,016 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Markel Group by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 1,172,997 shares of the insurance provider’s stock valued at $2,242,020,000 after acquiring an additional 5,184 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Markel Group by 1.8% in the 3rd quarter. Principal Financial Group Inc. now owns 547,188 shares of the insurance provider’s stock worth $1,045,947,000 after purchasing an additional 9,496 shares during the last quarter. Davis Selected Advisers boosted its position in Markel Group by 11.1% during the fourth quarter. Davis Selected Advisers now owns 415,160 shares of the insurance provider’s stock worth $892,496,000 after purchasing an additional 41,632 shares during the period. Finally, Select Equity Group L.P. boosted its position in Markel Group by 75.9% during the second quarter. Select Equity Group L.P. now owns 336,369 shares of the insurance provider’s stock worth $671,850,000 after purchasing an additional 145,146 shares during the period. 77.12% of the stock is currently owned by hedge funds and other institutional investors.

About Markel Group

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.